Welcome to the e-CCO Library!

P505: Efficacy of MMX-mesalamine monotherapy for maintenance of remission in ulcerative colitis patients after mucosal healing
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lopez-Diaz J., Ferreiro R., De la Iglesia D., Lorenzo A., Dominguez-Munoz J.E., Barreiro-de Acosta M.

Created: Wednesday, 20 February 2019, 10:36 AM
P505: Factors influencing outcomes from surgery for Crohn’s disease: A perspective from a district hospital
Year: 2018
Source: ECCO '18 Vienna
Authors:

A.R. Aspari*, N. Husain, P. Thomas

Created: Thursday, 21 February 2019, 9:14 AM
P505: Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn's disease: results from “long vedo” italian multicenter study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: MocciMD FRCP, G.(1)*;Maconi , G.(2);Onidi, F.M.(1);Cataletti, G.(2);Elisei , W.(3);Scaldaferri, F.(4);Lorenzetti , R.(5);Pagnini, C.(6);Scarcelli, A.(7);Graziani , M.G.(6);Di Paolo , M.C.(8);Pranzo, G.(9);Luppino, I.(9);Monterubbianesi, R.(10);Faggiani, R.(3);Ferronato, A.(11);Savarino, E.(12);Pica, R.(13);Cocco, A.(13);Rodino, S.(14); Sebkova, L.(15);Zampaletta, C.(16);Gaiani, F.(17);Fanigliulo, L.(18);Allegretta , L.(19);Cuomo, A.(20);Donnarumma, L.(21);Della Valle , N.(22);Forti, G.(23);Antonelli, E.(24);Bassotti , G.(24);Iannelli, C.(25);Aragona, G.(26);Lauria, A.(27);Piergallini, S.(28);Colucci, R.(29);Binaghi, L.(1);Meucci, C.(30);Papa, A.(4);Tursi, A.(31);
Created: Friday, 14 July 2023, 11:05 AM
P505: Real-world short-term effectiveness of ustekinumab in Crohn’s disease: Results from the ENEIDA Registry
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Iborra*1, B. Beltrán1, A. Fernández2, A. Gutiérrez3, B. Antolín4, J. M. Huguet5, R. de Francisco6, O. Merino7, D. Carpio8, S. García López9, F. Mesonero10, M. Mínguez11, R. Ferreiro12, A. Y. Carbajo13, M. Rivero14, M. Chaparro15, M. C. Piñero-Pérez16, D. Monfort i Miquel17, L. Bujanda18, M. F. García-Sepulcre19, A. Martín-Cardona20, F. Cañete21, C. Taxonera22, M. Sierra-Ausin23, J. Á. Ferrer-Rosique24, M. D. Martín-Arranz25, C. González-Muñosa26, N. Manceñido-Marcos27, I. Rodríguez-Lago28, E. Iglesias-Flores29, A. Forés-Bosch30, M. Navarro-Llavat31, M. Calafat32, R. E. Madrigal-Domínguez33, L. Ramos34, M. Arroyo35, D. Busquets36, R. Lorente37, E. Saiz-Arnau38, A. Hernández-Camba39, V. Jair-Morales40, C. Paredes41, M. Van Domselaar42, D. Hervás43, A. Cañada-Martínez43, P. Nos43

Created: Friday, 22 February 2019, 9:41 AM
P505: Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: TheodorakiMD- MA- PhD c, E.(1);Orfanoudaki, E.(2);Foteinogiannopoulou, K.(2);Koutroubakis, I.(2);
Created: Friday, 11 February 2022, 3:56 PM
P505: The effect of using a question prompt list in outpatient clinic consultations in a Dutch inflammatory bowel disease population
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Peek-Kuijt*1, M. de Jong1, N. Srivastava2, R. Veenendaal1, P. Maljaars1, L. van Bodegom-Vos3, A. Linn4, A. van der Meulen-de Jong1

Created: Friday, 22 February 2019, 9:49 AM
P506 Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Yanai1,2, S. Amir2, I. Avni Biron1,2, T. Tsadok Perets1,2, R. Shamir2,3, I. Dotan1,2, A. Assa2,3

Created: Thursday, 30 January 2020, 10:12 AM
P506: Endoscopic and clinical outcomes of upadacitinib in patients with moderate to severe Crohn's disease by baseline disease severity
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Siegmund, B.(1)*;Patel, K.(2);Torres, E.A.(3);Lakatos, P.L.(4,5);Seidelin, J.(6);Fleisher, M.(7);Ford, S.(8);Remple, V.(8);Lacerda, A.P.(8);Anyanwu, S.(8);Garrison, A.(8);Panés, J.(9);
Created: Friday, 14 July 2023, 11:05 AM
P506: Incidence risk of colorectal cancer, non-melanoma skin cancers and non-Hodgkin lymphoma in Japanese patients with ulcerative colitis based on large-scale claims database
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Kobayashi1*, A. Uda2, T. Mineyama2, E. Udagawa2, K. Iwasaki3, W. Tang3, T. Hibi1

Created: Thursday, 21 February 2019, 9:14 AM
P506: Psychological factors and quality of life in inflammatory bowel diseases patients: the Psycho study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Vegni E.1, Gilardi D.2, Corrò B.E.3, Menichetti J.4, Leone D.1, Allocca M.2, Bonovas S.5, Furfaro F.2, Danese S.2,6, Fiorino G.*7

Created: Wednesday, 20 February 2019, 10:36 AM
P506: Rates of clinical remission among patients with Ulcerative Colitis from real-world clinical practice settings from Germany
Year: 2022
Source: ECCO'22
Authors: Bokemeyer, B.(1);Picker, N.(2);Kromer, D.(2);Rosin, L.(3);Patel, H.(4);
Created: Friday, 11 February 2022, 3:56 PM
P506: Serum infliximab and antibodies to infliximab levels in Crohn’s disease and ulcerative colitis patients on long-term maintenance therapy
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Waterman*1, H. Bar Yoseph1, B. Ungar2, S. Ben - Horin2, Y. Chowers1

Created: Friday, 22 February 2019, 9:49 AM
P506: Steroid treatment for longer than 2 weeks leading to admission predicts higher colectomy rates in children with acute severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Tzivinikos*1, J. Jeng2, S. Nevitt2, C. Baillie1, S. Subramanian3, M. Auth1

Created: Friday, 22 February 2019, 9:41 AM
P506: The Impact of Anxiety in Patients With Inflammatory Bowel Diseases Treated With Biologics during COVID Lockdown. A Comparative Study between Hospitalized and non-hospitalized patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Bertani, L.(1,2);Barberio, B.(3);Zanzi, F.(1);Maniero, D.(3);Ceccarelli, L.(4);Marsilio, I.(3);Minciotti, M.(2);Coppini, F.(1);Lorenzon, G.(3);Mumolo, M.G.(4);Zingone, F.(3);Costa, F.(4);Savarino, E.V.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P507 Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Gadhok1, K. Fragkos2, S. Honap3, J. Hassan2, L. Whiteley2, A. Ibarra1, N. Burgess1, R. Vega2, E. Seward2, S. Mehta2, S. McCartney2, S. Bloom2, G. Parkes1, P. Irving3, J.O. Lindsay1, K.B. Kok1, F. Rahman2

Created: Thursday, 30 January 2020, 10:12 AM
P507: Clinical role, optimal timing and frequency of measurement of serum infliximab levels and anti-infliximab antibody titres in patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Bor*1, K. Farkas1, A. Bálint1, A. Milassin1, M. Rutka1, M. Matuz2, F. Nagy1, A. Fábián1, Z. Szepes1, T. Molnar1

Created: Friday, 22 February 2019, 9:49 AM
P507: Efficacy of Infliximab after failure of subcutaneous anti-TNF agents in patients with moderate-to-severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Viazis*1, E. Tsoukali1, M. Galanopoulos1, C. Pontas1, G. Karampekos1, G. Filippidis1, O. Giouleme2, G. Theocharis3, M. Tzouvala4, E. Archavlis1, A. Christidou1, G. J. Mantzaris1

Created: Friday, 22 February 2019, 9:41 AM
P507: Need for surgery in patients with ulcerative colitis in the era of biologic therapy.
Year: 2022
Source: ECCO'22
Authors: Zamora Olaya, J.M.(1);Aparicio-Serrano, A.(1);Gómez Pérez, A.(1);Ortiz Chimbo, D.S.(1);Rodríguez Tirado, M.I.(1);Soto Escribano, P.(1);Marín Pedrosa, S.(1);Iglesias Flores, E.(1);Benítez, J.M.(1);
Created: Friday, 11 February 2022, 3:56 PM
P507: Nutrition status in pre-surgical Crohn's disease, active Crohn's disease, Crohn's disease in remission and ulcerative colitis in remission: a cross-sectional study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sandall A.M.*1, Patel K.V.2, O'Hanlon D.V.3, Smith S.J.1, Darakhshan A.A.4, Sanderson J.D.2, Lomer M.C.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P507: United States and European patient perspectives on the impact of moderate-to-severe Ulcerative Colitis on sexual activity: Communicating Needs and Features of IBD Experiences (CONFIDE) survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Travis, S.(1)*;Bleakman, A.(2);Dubinsky, M.(3);Rubin, D.(4);Panaccione, R.(5);Hibi, T.(6);Kayhan, C.(2);Gibble, T.H.(2);Sapin, C.(2);Flynn, E.(2);Atkinson, C.(7);Schreiber, S.(8);
Created: Friday, 14 July 2023, 11:05 AM